EU-GMP Certified · MHRA Pathway Compliant
Pharmaceutical-Grade
Medical Cannabis
for the United Kingdom
Trusted by 120,000+ patients across Europe — now available for UK patients and clinicians.
Get Started
Who Are You?
Find the information and services relevant to your role in UK medical cannabis.
EU-GMP Certified
Sample Products from Our Formulary
All Cannamedical Britannia products are EU-GMP certified and prescribed exclusively through registered UK medical cannabis clinics.
Indica forte
Dried Flower • EU-GMP Certified
THC30 Cannabis Extract
Cannabis Extract Oil • EU-GMP Certified
Medical cannabis is a prescription-only medicine in the UK. Products are available exclusively through GMC-registered specialist clinics. Not available over the counter.
Medical cannabis is a Schedule 2 prescription-only medicine. Only GMC-registered specialist clinicians may issue initial prescriptions.
Browse Full Formulary →The Patient Journey
How to Get a Medical Cannabis Prescription
Medical cannabis is a specialist medicine prescribed through a private pathway. Here's how the UK process works.
Book a Consultation
Register with a GMC-registered medical cannabis specialist. Consultations available online and in-clinic across the UK.
Find a Specialist →Receive Your Prescription
Your specialist reviews your medical history and, where appropriate, issues a private prescription for an EU-GMP certified cannabis medicine.
View 15 Conditions →Collect From Pharmacy
A registered Schedule 2 UK pharmacy dispenses your prescription. Your specialist clinic will guide you to an appropriate dispensing pharmacy.
Find a Pharmacy →
About Cannamedical Britannia
Bringing European Pharmaceutical Excellence to the UK
Cannamedical Britannia is the British arm of Cannamedical Pharma GmbH, one of Europe's leading pharmaceutical-grade medical cannabis companies. As part of the Semdor Pharma Group, we operate under the highest EU-GMP standards.
We are building the MHRA-authorised supply chain to bring our full formulary of 100+ products to UK prescribing clinicians and dispensing pharmacies.
For Healthcare Professionals
Partnering with UK Clinics & Pharmacies
We work directly with prescribing clinicians and dispensing pharmacies to ensure seamless access to our pharmaceutical-grade formulary.
Prescribing Clinician Partnership
Access our full EU-GMP formulary, prescribing support materials, and partnership framework. Designed for specialist clinics and independent prescribers.
Partner With Us →
Dispensing Pharmacy Network
Join our dispensing pharmacy network. We provide dedicated pharmacy support, product training, and reliable supply chain for Schedule 2 medicines across the UK.
Join Our Network →Our Formulary
EU-GMP Certified Medical Cannabis Strains
United Kingdom
A Fast-Growing Medical Cannabis Market
Since legalisation in 2018, the UK medical cannabis market has expanded rapidly. With over 50,000 active patients, a clear MHRA regulatory pathway, and projected market value of £1.4 billion by 2029, the UK is one of Europe’s most significant pharmaceutical cannabis opportunities.
Medical Cannabis
Countries
Group-Wide
The Company
Part of Europe’s Leading Medical Cannabis Group
Cannamedical Britannia is the UK subsidiary of Semdor Pharma Group — one of Europe’s most established pharmaceutical medical cannabis distributors, headquartered in Cologne, Germany.
Since our founding, Cannamedical Pharma has built Europe’s most comprehensive EU-GMP formulary, serving over 120,000 patients across 15+ countries. Our UK entity is purpose-built to navigate the MHRA authorisation pathway and establish a compliant, scalable supply chain for the British market.
Careers
Build the UK’s Medical Cannabis Future
We are growing our UK team to establish Cannamedical Britannia as the leading pharmaceutical cannabis supplier for British patients and clinicians. Join us at the forefront of a pioneering healthcare sector.
Patient Resources
Medical Cannabis Guides & Information
15 May 2026
NHS Formulary Inclusion for Medical Cannabis: What It Would Take
The Current State of NHS Cannabis Prescribing NHS prescribing of cannabis-based medicines remains extremely limited in practice NICE guidelines support…
Read More →
15 May 2026
Cannabis Product Liability and Insurance for Clinicians
Professional Indemnity for Medical Cannabis Prescribers All clinicians prescribing cannabis in the UK require professional indemnity insurance Standard MDU or…
Read More →
15 May 2026
Medical Cannabis in Northern Ireland: Access, Law, and What Patients Need to Know
The Legal Framework in Northern Ireland Medical cannabis in Northern Ireland falls under UK-wide legislation — the Misuse of Drugs…
Read More →Partner With Us
Are you a prescribing clinician or dispensing pharmacy?
Contact our UK partnerships team to discuss formulary access, product data, and our MHRA authorisation timeline.


